GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BOLT
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Thursday for Bolt Biotherapeutics, Inc. stock after gaining 2.70%
(Updated on Apr 18, 2024)

Sell candidate since Apr 17, 2024 Gain 2.70% PDF

The Bolt Biotherapeutics, Inc. stock price gained 2.70% on the last trading day (Thursday, 18th Apr 2024), rising from $1.11 to $1.14. During the last trading day the stock fluctuated 4.50% from a day low at $1.11 to a day high of $1.16. The price has fallen in 5 of the last 10 days and is down by -14.29% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 15 thousand more shares were traded than the day before. In total, 89 thousand shares were bought and sold for approximately $101.96 thousand.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.11 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 15.25% during the next 3 months and, with a 90% probability hold a price between $1.28 and $1.78 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BOLT Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 2.70%. Further rise is indicated until a new top pivot has been found. Bolt Biotherapeutics, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Bolt Biotherapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.18 and $1.23. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Bolt Biotherapeutics, Inc. stock

Bolt Biotherapeutics, Inc. finds support from accumulated volume at $1.11 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0500 between high and low, or 4.50%. For the last week, the stock has had daily average volatility of 6.05%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BOLT) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Bolt Biotherapeutics, Inc. to open at $1.14, and during the day (based on 14 day Average True Range), to move between $1.06 and $1.22, which gives a possible trading interval of +/-$0.0797 (+/-6.99%) up or down from last closing price. If Bolt Biotherapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 13.99% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.11 (2.63%) than the resistance at $1.20 (5.26%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Bolt Biotherapeutics, Inc. stock A Buy?

The Bolt Biotherapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Bolt Biotherapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.473 Sell Candidate Unchanged

Predicted Opening Price for Bolt Biotherapeutics, Inc. of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$1.14 ( 0.292%) $1.14

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BOLT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.19 4.09 %
R2 1.17 2.42 %
R1 1.16 1.38 %
Current price: 1.14
Support S1 1.12 -1.97 %
S2 1.11 -3.00 %
S3 1.09 -4.68 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.40 22.81 %
R2 1.27 11.40 %
R1 1.20 5.26 %
Current price 1.14
Support S1 1.11 -2.63%
S2 1.10 -3.51%
S3 1.08 -5.26%

BOLT Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Aug 13, 2014 Aug 29, 2014 Oct 02, 2014 $0.0900 0%
2 Apr 24, 2014 Jun 10, 2014 Jul 09, 2014 $0.0900 0%
3 Jan 22, 2014 Mar 03, 2014 Apr 02, 2014 $0.0900 0%
4 Nov 27, 2013 Dec 30, 2013 Jan 15, 2014 $0.0900 0%
5 Aug 14, 2013 Sep 03, 2013 Oct 03, 2013 $0.0900 0%

FAQ

What is the symbol for Bolt Biotherapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Bolt Biotherapeutics, Inc. is BOLT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Bolt Biotherapeutics, Inc. Stock?
The Bolt Biotherapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Bolt Biotherapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Bolt Biotherapeutics, Inc. Stock?
Bolt Biotherapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Bolt Biotherapeutics, Inc. Stock.

What's the current price of Bolt Biotherapeutics, Inc. Stock?
As of the end of day on the 2024-04-18, the price of an Bolt Biotherapeutics, Inc. (BOLT) share was $1.14.

What is the 52-week high and low for Bolt Biotherapeutics, Inc. Stock?
The 52-week high for Bolt Biotherapeutics, Inc. Stock is $2.03 and the 52-week low is $0.84.

What is the market capitalization of Bolt Biotherapeutics, Inc. Stock?
As of the 2024-04-18, the market capitalization of Bolt Biotherapeutics, Inc. is 43.466M.

When is the next earnings date for Bolt Biotherapeutics, Inc. ?
The upcoming earnings date for Bolt Biotherapeutics, Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics. Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors; BDC-2034, a carcinoembryonic antigen program for col... BOLT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT